Motohiro Sekino

Professor

Saga University
Country flagJapan

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (9)

Year:

2026

Liver transplantation for patients with hemophilia and HIV/HCV coinfection presents unique challenges due to the complexity of perioperative management, including coagulation disorders, drug interactions, and potential complications such as pulmonary hypertension. We report a successful case of brain‐dead donor liver transplantation in a patient with hemophilia B and HIV/HCV coinfection, complicated by pulmonary hypertension. The patient, a man in his 50s, acquired multidrug‐resistant HIV and HCV in childhood from contaminated blood products. Despite successful HCV eradication, liver function declined, and he was listed for transplantation. Preoperative evaluation revealed pulmonary arterial hypertension, which improved with sildenafil citrate, macitentan, and home oxygen therapy. Intraoperatively, coagulation was managed with factor IX supplementation, and circulation remained stable following reperfusion. Postoperatively, immunosuppression, antiretroviral therapy, and treatment for pulmonary hypertension were carefully coordinated to avoid drug interactions. Nitric oxide therapy was utilized to improve oxygenation. The patient was discharged on postoperative day 51 with normal liver function and good overall condition. This case underscores the importance of multidisciplinary collaboration and careful perioperative planning in achieving successful outcomes in liver transplantation for patients with complex comorbidities such as hemophilia, HIV/HCV coinfection, and pulmonary hypertension.

Year:

2026

Year:

2026

Rationale: Amniotic fluid embolism (AFE) is a fatal obstetric condition that often rapidly leads to severe respiratory and circulatory failure. It is complicated by obstetric disseminated intravascular coagulation (DIC) with bleeding tendency; therefore, the introduction of venoarterial extracorporeal membrane oxygenation (VA-ECMO) is challenging. We report the case of a patient with AFE requiring massive blood transfusion, rescued using VA-ECMO without initial anticoagulation. Patient’s concerns: A 39-year-old pregnant patient was admitted with a complaint of abdominal pain. An emergency cesarean section was performed because a sudden decrease in fetal heart rate was detected in addition to DIC with hyperfibrinolysis. Intra- and post-operatively, the patient had a bleeding tendency and required massive blood transfusions. After surgery, the patient developed lethal respiratory and circulatory failure, and VA-ECMO was introduced. Diagnosis: Based on the course of the illness and imaging findings, the patient was diagnosed with AFE. Interventions: By controlling the bleeding tendency with a massive transfusion and tranexamic acid administration, using an antithrombotic ECMO circuit, and delaying the initiation of anticoagulation and anti-DIC medication until the bleeding tendency settled, the patient was managed safely on ECMO without complications. Outcomes: By day 5, both respiration and circulation were stable, and the patient was weaned off VA-ECMO. Mechanical ventilation was discontinued on day 6. Finally, she was discharged home without sequelae. Lessons: VA-ECMO may be effective to save the lives of patients who have AFE with lethal circulatory and respiratory failure. For safe management without bleeding complications, it is important to start VA-ECMO without initial anticoagulants and to administer anticoagulants and anti-DIC drugs after the bleeding tendency has resolved.

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (2)

Shuntaro Sato

Nagasaki University

JAPAN
View details

Shohei Kaneko

Nagasaki University Hospital

JAPAN
View details